• ESWT was associated with significantly better scores than comparison therapy on the visual analog scale for pain (P < .01), American Orthopaedic Foot & Ankle Society scale (P = .01), Likert scale for satisfaction (P = .03), Roles and Maudsley scale (P < .01), Victorian Institute of Sports Assessment - Achilles questionnaire (P < .01), and numerical rating scale (P = .02). • The 2 patient groups did not differ significantly in tenderness (P = .34) or pain threshold (P = .24). • Subgroup analysis showed that ESWT led to better VAS pain scores than comparison treatments at both low-energy level (0.06-0.11 mJ/mm2) and medium-energy level (0.12-0.25 mJ/mm2) and at both shorter (<6 months) and longer (≥6 months) follow-up. ESWT improves pain and functional outcomes in patients with Achilles tendinopathy. Further research is needed to determine the optimal energy level. Opinion Search keywords and subject headings, included: extracorporeal shockwave therapy (extracorporeal shockwave therapies, shockwave therapies, extracorporeal, shockwave therapy, extracorporeal, therapy, extracorporeal shockwave, shock wave therapy, shock wave therapies, therapy, shock wave, extracorporeal shock wave therapy, extracorporeal high intensity focused ultrasound therapy, extracorporeal high intensity focused ultrasound therapy, HIFU therapy, HIFU therapies, therapy, HIFU, high-intensity focused ultrasound therapy, high intensity focused ultrasound therapy More studies with less bias to focused shockwave may have been found if the search keywords included Radial Pressure Wave and Extracorporeal Activation Therapy.
Results
Conclusion
Key message
There appears to be good evidence to support the use of ESWT in the management of Achilles tendinopathies
Pubmed
https://pubmed.ncbi.nlm.nih.gov/33283015/
14
Made with FlippingBook - PDF hosting